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Yokukansan, a traditional Japanese herbal medicine, has been considered to be a novel alternative
treatment for several neurological diseases such as neurodegenerative disorders, as well as neurosis,
insomnia, and behavioral and psychological symptoms in Alzheimer's disease. Moreover, it has been
shown that yokukansan has antidepressant-like and pain-relieving effects in animal models. Recently,
several studies have shown that yokukansan has a neuroprotective effect. In this study, we focused on
whether or no yokukansan inﬂuences cell proliferation related to cell-cycle progression by using B65
neuroblastoma cells derived from monoaminergic neurons. Under treatment with yokukansan, the
proliferation rate of B65 neuroblastoma cells signiﬁcantly increased in a dose-dependent manner. In
particular, a proliferative effect was observed after treatment with yokukansan for 48 h and 72 h.
Moreover, among seven medicinal herbs that comprise yokukansan, both Bupleuri Radix and Glycyrrhize
Radix also enhanced the proliferation of B65 neuroblastoma cells. We assessed the effect of yokukansan
on p44/42 mitogen-activated protein kinase (MAPK) phosphorylation in B65 neuroblastoma cells, and
found that yokukansan increased p44/42 MAPK phosphorylation after treatment for 48 h. In contrast,
neither Bupleuri Radix nor Glycyrrhize Radix altered the level of p44/42 MAPK phosphorylation, although
they did increase cell proliferation. Our ﬁndings suggest that yokukansan has a cell-proliferative due to
both Bupleuri Radix and Glycyrrhize Radix, and this is unrelated to the p44/42 MAPK signaling cascade.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Yokukansan is a traditional Japanese herbal medicine. It origi-
nated from the traditional Chinese herbal medicine Yi-Gan San,symptoms of dementia; ALR,
oma; UR, Uncariae Uncis cum
R, Glycyrrhize Radix; MAPK,
SRI, Selective serotonin reup-
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-1 Kitakanemaru, Ohtawara,
þ81 287 24 3521.
i).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).which was modiﬁed to create a unique Japanese herbal medicine
called “Kampo”. Yokukansan is composed of seven medicinal
herbs: Atractylodis lanceae Rhizoma (ALR), Poria (PR), Cnidii Rhizoma
(CR), Uncariae Uncis Cum Ramulus (UR), Angelicae Radix (AR),
Bupleuri Radix (BR) and Glycyrrhize Radix (GR). Since ancient times,
this herbal medicine has been used to treat patients with symp-
toms such as nervousness, short temper, irritability and sleepless-
ness in infants and young children.
Recently, clinical evidence regarding the effectiveness of yoku-
kansan has been reported. In particular, it has been demonstrated
that yokukansan can improve dementia and several psychiatric
conditions.1 Several clinical studies have shown that the adminis-
tration of yokukansan could ameliorate the symptoms of behav-
ioral and psychological symptoms of dementia (BPSD) inrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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neuropsychiatric symptoms associated with Parkinson's diseases,
including hallucinations, anxiety and apathy without severe
adverse events or worsening of Parkinsonism.4 According to the
clinical studies of yokukansan mentioned above, yokukansan may
have multiple components that are effective at treating various
central nervous system diseases. As a mechanism of the amelio-
rative effect against various central nervous system diseases, it is
has been considered that yokukansan has neuroprotective effects.
Several studies have demonstrated that yokukansan has a neuro-
protective effect against glutamate-induced excitotoxicity in
cultured cells,5,6 and this neuroprotective effect involves the
modiﬁcation of gene expression of cystine/glutamate antiporter
system Xc.7 We also previously reported that yokukansan showed
a neuroprotective effect against cytotoxicity induced by cortico-
sterone on mouse hippocampal neurons.8 In contrast, it has been
demonstrated, albeit in an animal experiment, that yokukansan
had antidepressive and antinociceptive effects on behavioral
despair and acetic acid-induced writhing in mice.9 Another animal
behavioral experiment revealed that yokukansan showed anxio-
lytic effects against experienced aversive stress in rat.10 Based on
this evidence, it is reasonable to consider that yokukansan might
contain some components that can improve nervousness, depres-
sion and anxiety disorder. Actually, several studies have stated that
yokukansan contains components that act as agonists or antago-
nists against several receptors.11,12 It has been reported that the
anxiolytic or antidepressant effects of yokukansan in rats that have
been exposed to experienced-aversive stress might be caused via
serotonin 5-HT1A receptor agonism.10,13 Therefore since 5-HT1A
agonist has an antidepressant-like effect, the antidepressant-like
effect induced by yokukansan may be due to stimulation of 5-
HT1A receptor. Moreover, chronic stress decreased the number of
neural stem cells in the subventricular zone, and an antidepressant,
such as selective serotonin reuptake inhibitor (SSRI), attenuated the
corticosteroid- or chronic stress-induced decrease in the viability
and proliferation of neuroblastoma or neural stem cells.14,15
Furthermore, it has been suggested that the ﬁnding that 5-HT1A
agonists increased cell proliferation in the adult central nervous
system may be related to antidepressive mechanisms.16 These
various ﬁndings suggest that some component(s) in yokukansan,
which has an antidepressive effect, may enhance cell proliferation
which is related to cell-cycle progression in neurogenesis or cell
survival.
In this study, we investigated whether or not yokukansan has a
cell-proliferative effect and the mechanism that underlies this
effect by using B65 neuroblastoma cell derived from mono-
aminergic neurons.2. Materials and methods
2.1. Materials
Yokukansan is composed of seven dried medicinal herbs: 4.0 g
of ALR, 4.0 g of PC, 3.0 g of CR, 3.0 g of UR, 3.0 g of AR, 2.0 g of BR and
1.5 g of GR. These herbs are registered in the Pharmacopeia of Japan
ver. 16. The powdered water extracts of yokukansan and each in-
dividual medicinal herb used in this study were manufactured ac-
cording to previously reported,8,17 and supplied by Tsumura & Co.
(Tokyo, Japan). A three-dimensional high-performance liquid
chromatography (3D-HPLC) proﬁle of representative batches of
yokukansan and each individual medicinal herb which were pro-
vided by Tsumura & Co. are shown in Fig. 1. All other materials for
experiments, including reagents, drugs, antibodies and media were
purchased from the companies indicated in each description.2.2. Cell culture
B65 neuroblastoma (DS Pharma Biomedical, Osaka, Japan) is a
rat ethyl nitrosourea-induced tumor cell line. Brieﬂy, B65 neuro-
blastoma cells were cultured in Dulbecco's modiﬁed Eagle's me-
dium (DMEM) with a high glucose concentration (Wako, Osaka,
Japan) supplemented with 10% heat-inactivated fetal bovine serum
(FBS, Biowest, Nuaille, France), 100 u/mL penicillin and 100 mg/mL
streptomycin (Wako, Osaka, Japan) in a humidiﬁed incubator under
a 95%/5% mixture of air and CO2. Cells were generally passaged
every 5 days.
2.3. Cell viability assay
The proliferation of B65 neuroblastoma cells was analyzed by a
WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium] assay using a Cell Counting Kit-8
(Dojindo, Kumamoto, Japan). Once cells became conﬂuent, they
were plated into 96-well microplates at a density of 5  104/mL
(5  103/well). To apply yokukansan or each individual medicinal
herb to B65 neuroblastoma cells, they were ﬁrst suspended in
culture media. The solution was then centrifuged for 5 min at
15,000  g to remove insoluble residue. To avoid denaturing the
effective component, the solution of cells dissolved in culture me-
dia was prepared immediately before every experiment. After
centrifugation, the supernatant was used in all experiments. At 24,
48 and 72 h of culture with yokukansan, the individual medicinal
herbs or chemical compounds, the cells were incubated with WST-
8 solution at 37 C for 2 h. The spectrophotometric absorbance of
WST-8-formazan produced by dehydrogenase activity in living cells
was measured at a wavelength of 450 nm using a VersaMax (Mo-
lecular Devices, Tokyo, Japan). Statistical analysis was performed by
using absolute absorbance values.
2.4. Western blotting
Protein samples were obtained from B65 neuroblastoma cells
that had been exposed to various concentrations of yokukansan or
individual medicinal herbs for 24, 48 and 72 h. For the preparation
of protein extract from B65 neuroblastoma cells, the cells were
washed with ice-cold homogenizing buffer (pH7.4; 250 mM su-
crose, 2 mM EDTA 2Na, 10 mM EGTA and 20 mM Tris-HCl), and
centrifuged to obtain a cell pellet. The cell pellet was treated with
lysis buffer (homogenizing buffer containing 1% Triton X-100 and a
protease inhibitor cocktail) and sonicated on ice. After the sample
was centrifuged, the supernatant was collected as a total protein
extract. For western blotting, protein extracts were placed on SDS-
polyacrylamide gel, transferred to a polyvinylidene diﬂuoride
membrane (BioRad, Hercules, CA, U.S.A) and immunoblotted with
anti-p44/42 mitogen-activated protein kinase (MAPK) polyclonal
antibody (Cell Signaling Technology, Danvers, MA, U.S.A., 1:1000),
anti-phospho-p44/42 MAPK polyclonal antibody (Cell Signaling
Technology, Danvers, MA, U.S.A., 1:1000) and anti-glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) monoclonal antibody (Mil-
lipore, Billerica, MA, U.S.A., 1:5000). The blots were developed with
horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse
IgG (Jackson ImmunoResearch, West Grove, PA, U.S.A., 1:20000)
and visualized by chemiluminescence using an ECL prime Western
Blotting Detection System (Amersham, Piscataway, NJ, USA) and
Western BLoT Quant HRP Substrate (TaKaRa, Ootsu, Japan).
2.5. [3H]Serotonin uptake assay
Approximately 4  104 B65 neuroblastoma cells were divided
equally into 24-well plates. [3H]Serotonin (5-HT) uptake assays
Fig. 1. Three-dimensional HPLC proﬁles of yokukansan, UR, BR, AR, CR, ALR, GR and PR. Each peak of yokukansan and each individual medicinal herb comprising yokukansan in the
HPLC proﬁle was identiﬁed by comparison of the retention times and UV spectra (200e400 nm) of chemically deﬁned standard compounds.
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Fig. 2. Serotonin uptake in B65 neuroblastoma cells. [3H]5-HT uptake assays were
carried out 72 h after passaging of cells. [3H]5-HT was measured when cells were
incubated for 15 min at 37 C in the presence of 100 nM [3H]5-HT. Shaded column
shows the raw uptake of [3H]5-HT by B65 neuroblastoma cells. On the other hand,
open column indicates the net uptake of [3H]5-HT by B65 neuroblastoma cells, which
was calculated by subtracting the uptake of [3H]5-HT cultured with 10 mM ﬂuvoxamine
from the raw uptake of [3H]5-HT. Columns show means ± S.D (n ¼ 4).
Fig. 3. Cell proliferative effect of yokukansan on B65 neuroblastoma cells. (A) Images of
B65 neuroblastomacells culturedwith andwithout 500 mg/mLyokukansan. Pictureswere
taken after treatment with 500 mg/mL yokukansan for 48hr. The scale bars represent
500 mm. (B) WST-8 cell proliferation assay of B65 neuroblastoma cells cultured with or
without various concentrations of yokukansan after treatment for 24, 48 and 72 h. The
vertical axis shows the proliferation rate relative to that in the control without yoku-
kansan. The histogram shows means ± S.D (n ¼ 3). When the absolute absorbance value
was statistically different from control without yokukansan, it was considered to be sta-
tistically signiﬁcant (*; p < 0.05 vs. control absolute absorbance value).
Y. Nakatani et al. / Journal of Traditional and Complementary Medicine 7 (2017) 34e44 37were carried out 72 h after passaging of cells. In brief, the culture
medium was removed and then cells were incubated for 15 min at
37 C in the presence of 100 nM [3H]5-HT. The uptake of [3H]5-HT
was stopped by washing the cells. After cells were lysed, the
radioactivity of cell extracts was measured as the total [3H]5-HT
uptake by cells. In contrast, the radioactivity of cell extracts that
were obtained from cells incubated with 10 mM ﬂuvoxamine was
considered to be nonspeciﬁc [3H]5-HT uptake by cells. The net [3H]
5-HT uptake by cells was calculated as the difference between total
[3H]5-HT uptake and nonspeciﬁc [3H]5-HT uptake.2.6. Statistics
The results are presented as themean ± S.D. A statistical analysis
was performed using the Dunnett multiple comparisons test. A p
value < 0.05 was considered to be statistically signiﬁcant.Table 1
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Bupleuri Radix (BR) 589.0 103.1 17.5
Angelicae Radix (AR) 424.1 136.9 32.3




Glychrrhizae Radix (GR) 500.0 141.3 28.3
Poria (PR) 615.8 6.2 1.03. Results
3.1. Serotonin uptake by B65 neuroblastoma cells
First, we investigated whether or not B65 neuroblastoma cells
can uptake 5-HT, since they are considered to be monoaminergic as
well as dopaminargic neurons. As shown in Fig. 2, a [3H]5-HT-up-
take assay showed that B65 neuroblastoma cells can uptake 5-HT.
The uptake of [3H]5-HT by cells, including via both 5-HT transporterkukansan.
ered
(%)
Composition rate of crud
medicinal herb component
in yokukansan (g)
Composition rate of powdered water extact
from crude medicinal herb component in








Fig. 4. Cell proliferative effects of extracts of the medicinal herbs comprising yokukansan on B65 neuroblastoma cells. WST-8 cell proliferation assay of B65 neuroblastoma cells
cultured with various concentrations of UR, BR, AR, CR, ALR, GR and PC after treatment for 24, 48 and 72 h. The vertical axis shows the proliferation rate relative to that in the control
without the test compounds. The histogram shows means ± S.D (n ¼ 3). When the absolute absorbance value was statistically different from control without each medicinal herbs
comprising yokukansan, it was considered to be statistically signiﬁcant (*; p < 0.05 vs. control absolute absorbance value).
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Fig. 5. Cell proliferative effect of the combination of BR and GR on B65 neuroblastoma
cells. WST-8 cell proliferation assay of B65 neuroblastoma cells cultured with or
without various concentrations of the combination of BR and GR after treatment for 24,
48 and 72 h. The vertical axis shows the proliferation rate relative to that in the control
without these compounds. The histogram shows means ± S.D (n ¼ 3). When the ab-
solute absorbance value was statistically different from control without BR and GR, it
was considered to be statistically signiﬁcant (*; p < 0.05 vs. control absolute absor-
bance value).
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uptake of [3H]5-HT by cells treated with the SSRI ﬂuvoxamine was
21.07 ± 1.40 cpm/mg, which means that this amount of [3H]5-HT
uptake did not occur through 5-HT transporter. The net uptake of
[3H]5-HT was 71.03 ± 2.98 cpm/mg. This ﬁnding strongly supported
the notion that B65 neuroblastoma cells have some of the same
features as serotonergic neurons and it is reasonable to use these
cells to examine antidepressive effects.
3.2. Cell proliferative effect of yokukansan on B65 neuroblastoma
cells
Since antidepressants, such as 5-HT1A agonist or SSRI, have been
demonstrated to have cell proliferative effects on neural stem cells
or neuroblastoma cells derived from monoaminergic neurons, weFig. 6. Effect of yokukansan on the acute expression of phosphorylated and total p44/42 MA
42 MAPK by B65 neuroblastoma cells cultured with or without various concentrations of yo
and total p44/42 MAPK are shown as the relative ratio on the basis of the expression of GAinvestigated whether or not yokukansan has a cell proliferative
effect on B65 neuroblastoma cells. The cell proliferation rate was
slightly but signiﬁcantly decreased after treatment with more than
10 mg/mL of yokukansan for 24 h, compared with the control
condition without yokukansan. However, after treatment with
yokukansan for 48 h and 72 h, the cell proliferation rate signiﬁ-
cantly increased in a dose- and time-dependent manner (Fig. 3A
and B).
3.3. Cell proliferative effects of extracts of the medicinal herbs that
comprise yokukansan on B65 neuroblastoma cells
Since yokukansanwas shown tohave a cell proliferative effect on
B65 neuroblastoma cells, we sought to identify which of its con-
stituentmedicinal herbs are responsible for this effect. In thepresent
study, it is reasonable to consider that the component that produces
the cell proliferative effect is water-soluble because it should
dissolve in the culture medium. Therefore, we calculated the con-
centration of each medicinal herb extract from the composition of
the powdered water extract from the crude drug component in
yokukansan, and show these concentrations in the right-most col-
umn in Table 1. Fig. 4 shows the cell proliferative effect of each
medicinal herb extract from the crude drugs that comprise yoku-
kansan. The extracts of two of the seven constituentmedicinal herbs
(BR and GR) slightly, but signiﬁcantly, enhanced cell proliferation.
Under treatment with BR, cell proliferative effect was observed at
relatively low concentrations, which were between 0.09 to 0.18 mg/
mL of BR, after treatment for 48 h and 72 h. The relative cell prolif-
eration rate of 0.09e9 mg/mL BR increased, and the relative cell
proliferation rate of 0.9 mg/mL BR increased to 122.28 ± 5.70 %
compared to that of the control after treatment for 72 h. In addition,
GR had a cell proliferative effect at a mid-range concentration, and
this effect was signiﬁcant after treatment with GR for 72 h. In
particular, the relative cell proliferation rate of 0.55e5.5 mg/mL GR
increased, and the relative cell proliferation rate of 1.1 mg/mL GR
increased to 154.01 ± 9.01 % compared to that in the control after
treatment for 72 h (Fig. 4). On the other hand, neither UR, AR, CRALR
nor PC signiﬁcantly increased cell proliferation (Fig. 4). We also
investigatedwhether or not treatmentwith a combination of BR and
GR increased the proliferation of B65 neuroblastoma cells. As shown
in Fig. 5, similar to treatmentwith BR andGR individually, treatment
with the combination of 45 mg/mL BR and 55 mg/mL GR for 48 h and
72 h increased the proliferation of B65 neuroblastoma cells to
122.16± 5.97 % and 125.32± 4.77 %, respectively (Fig. 5). In addition,
treatment with the combination of 90 mg/mL BR and 110 mg/mL GRPK in B65 neuroblastoma cells. The protein expression of phosphorylated and total p44/
kukansan after treatment for 30 min. The relative expressions of both phosphorylated
PDH. The histogram shows means ± S.D (n ¼ 3, *; p < 0.05 vs. control).
Y. Nakatani et al. / Journal of Traditional and Complementary Medicine 7 (2017) 34e4440for 48 h and 72 h also increased the proliferation of B65 neuro-
blastoma cells to 126.22 ± 9.87 % and 125.99 ± 8.99 %, respectively
(Fig. 5).3.4. Effects of yokukansan, Bupleuri Radix and Glycyrrhize Radix on
p44/42 mitogen-activated protein kinase phosphorylation
The phosphorylation of p44/42 MAKP plays a role in cell sur-
vival, proliferation and differentiation, and this phosphorylation
usually occurs acutely, within approximately 30 min. First, the
acute change in p44/42 MAPK phosphorylation was investigated
by western blotting analysis of B65 neuroblastoma cells. Under
treatment with various concentrations of yokukansan for 30 min,
there were no changes in the expression levels of phosphorylated-
p44/42 MAPK. The expression levels of p44/42 MAPK also did notFig. 7. Effect of yokukansan on the sustainable expression of phosphorylated and total p44/4
p44/42 MAPK by B65 neuroblastoma cells cultured with or without various concentration
phosphorylated and total p44/42 MAPK are shown as the relative ratio on the basis of the exchange under treatment with various concentrations of yoku-
kansan (Fig. 6). Sustainable p44/42 MAPK phosphorylation was
also investigated, and we found that the expression level of
phosphorylated-p44/42 MAPK was signiﬁcantly increased by
treatment with 500 mg/mL yokukansan for 48 h (Fig. 7). In
contrast, there were no signiﬁcant changes in p44/42 MAPK
phosphorylation under various other culture conditions, although
the expression levels of phosphorylated-p44/42 MAPK tended to
increase (Fig. 7). The expression levels of p44/42 MAPK also did
not change under treatment with various concentrations of
yokukansan.
Moreover, to clarify whether the phosphorylation of p44/42
MAPK under treatment with yokukansan results from some
components of BR or GR, western blotting analysis was per-
formed under the same condition as for yokukansan treatment.2 MAPK in B65 neuroblastoma cells. The protein expression of phosphorylated and total
s of yokukansan after treatment for 24, 48 and 72 h. The relative expressions of both
pression of GAPDH. The histogram shows means ± S.D (n ¼ 5e6, *; p < 0.05 vs. control).
Fig. 8. Effect of BR on the sustainable expression of phosphorylated and total p44/42 MAPK in B65 neuroblastoma cells. The protein expression of phosphorylated and total p44/42
MAPK by B65 neuroblastoma cells cultured with or without various concentrations of BR after treatment for 24, 48 and 72 h. The relative expressions of both phosphorylated and
total p44/42 MAPK are shown as the relative ratio on the basis of the expression of GAPDH. The histogram shows means ± S.D (n ¼ 3e6, *; p < 0.05 vs. control).
Y. Nakatani et al. / Journal of Traditional and Complementary Medicine 7 (2017) 34e44 41Unexpectedly, neither BR nor GR affected the phosphorylation of
p44/42 MAPK under various culture conditions, although both BR
and GR, like yokukansan, had a cell proliferative effect (Figs. 8
and 9).
4. Discussion
Based on various clinical studies which showed that yoku-
kansan is effective in treating some neurological diseases, such as
BPSD,1 several studies have demonstrated that yokukansan pos-
sesses a cell proliferative effect, cell protective effect or neuro-
trophic effect in various cell lines derived from neurons or neurons
in primarily culture.8,18 In animal studies, it has been reported that
treatment with yokukansan could ameliorate anxiety-like
behavior and alleviate emotional abnormality in mice.13,19
Recently, several studies have indicated that depression iscaused by an adult neurogenesis disturbance in the central ner-
vous system. Actually, it has been demonstrated that adult neu-
rogenesis in the hippocampus is disturbed by stress stimuli or
glucocorticoid which is known to be released under stressful
conditions,20 and this disturbance is restored by treatment with an
antidepressant.21 In addition, yokukansan has the potential to
increase hippocampal neurogenesis associated with the suppres-
sion of activated microglia.22 Furthermore, several studies related
to pharmacokinetics of yokukansan have demonstrated that
several compounds contained to yokukansan migrate to both
plasma and brain after oral administration in in vivo experi-
ments.23,24 According to these studies, it is reasonable to consider
that yokukansan and its compounds would distribute to the brain
by oral administration and be effective for the treatment of
depression or anxiety disorder and the mechanism may be similar
to those of antidepressants. However, most in vitro studies have
Fig. 9. Effect of GR on the sustainable expression of phosphorylated and total p44/42 MAPK in B65 neuroblastoma cells. The protein expression of phosphorylated and total p44/42
MAPK by B65 neuroblastoma cells cultured with or without various concentrations of GR after treatment for 24, 48 and 72 h. The relative expressions of both phosphorylated and
total p44/42 MAPK are shown as the relative ratio on the basis of the expression of GAPDH. The histogram shows means ± S.D (n ¼ 5e9, *; p < 0.05 vs. control).
Y. Nakatani et al. / Journal of Traditional and Complementary Medicine 7 (2017) 34e4442been insufﬁcient to explain the effect of yokukansan on neuronal
function because the neuronal cells used in those studies either
were unknown or were neuroblastoma cells derived from dopa-
minergic, but not serotonergic, neurons. In this respect, B65 neu-
roblastoma are advantageous because they can uptake 5-HT, as
shown to Fig. 2, which means that B65 neuroblastoma cells have
the same features as serotonergic neurons.
First, we investigated whether yokukansan, like antidepressants,
has a cell proliferative effect on B65 neuroblastoma cells. When B65
neuroblastoma cellswere treatedwithyokukansan, cell proliferation
increased in a dose-dependent manner. Since antidepressants
recovered the proliferation of SH-SY5Y neuroblastoma cells that had
been suppressed by treatment with dexamethasone,14 the
enhancement of the proliferative effect of yokukansan on B65 neu-
roblastoma cells may indicate that the action mechanism ofyokukansan resembles that of antidepressants. Moreover, antide-
pressants propagated the expression of brain-derived neurotrophic
factor mRNA in a time-dependent manner.25 These ﬁndings suggest
that yokukansan may increase neurogenesis and potentiate the
production of neurotrophic factor from neurons.
Next, we also considered that yokukansan may affect the
phosphorylation of p44/42 MAPK because imipramine attenuated
the decrease in p44/42 MAPK phosphorylation induced by dexa-
methasone.14 Moreover, the fact that the phosphorylation of p44/
42 MAPK is important for cell-cycle progression, such as cell pro-
liferation, survival and neuronal differentiation, should let us
investigate the expression level of phosphorylated-p44/42MAPK.26
When we investigated the effect of yokukansan on expression
levels of phosphorylated-p44/42 MAPK in B65 neuroblastoma cells,
the transient elevation of phosphorylated-p44/42 MAPK
Y. Nakatani et al. / Journal of Traditional and Complementary Medicine 7 (2017) 34e44 43expressionwas observed after treatment with yokukansan for 48 h.
This result indicated that yokukansan may affect the cell signaling
cascade in a similar manner as antidepressants.
Furthermore, we tried to identify which medicinal herb(s)
contained the component with the cell proliferative effect and p44/
42 MAPK-phosphorylated effect on B65 neuroblastoma cells. BR
and GR each signiﬁcantly increased the proliferation of B65 neu-
roblastoma cells. This result was unexpected because some reports
have stated that both BR and GR contain anti-proliferative com-
pounds.27,28 However, another study demonstrated that BR has a
cell proliferative effect.29 Several kampo prescriptions such as
hochuekkito or shosaikoto have not been reported that they have
the effect to enhance cell proliferation which is related to cell-cycle
progression although both of them also contains BR and GR like
yokukansan. Considering that kampo prescription composes
various medicial herbs, some of components contained to
hochuekkito or shosaikoto may mask the effect of BR and GR to
enhance cell proliferation.
These differences may be due to the cell types or the method
used to prepare the medicinal herb extract. Furthermore, we
explored whether BR or GR, like yokukansan, also increased the
expression level of phosphorylated-p44/42 MAPK. Surprisingly,
neither BR nor GR affected the expression level of phosphorylated-
p44/42 MAPK. These ﬁndings indicate that the cell proliferative
effect of yokukansan does not correlatewith the phosphorylation of
p44/42 MAPK. It is possible that multiple components of yoku-
kansan which have biological activity affect cell-cycle progression,
either with or without interaction with each other.5. Conclusion
Yokukansan and its medicinal herb extracts, BR and GR, inﬂu-
enced the proliferation of B65 neuroblastoma cells. Moreover,
yokukansan transiently enhanced the expression level of
phosphorylated-p44/42 MAPK. These ﬁndings suggest that BR and
GR may be main component to enhance cell viability and act as an
activator, like neurotrophic factor, to improve neuronal function
under malfunction of the central nervous system, such as in
depression or anxiety disorder. Further studies will be needed to
clarify the molecular mechanism by which yokukansan has an
antidepressive effect.Funding
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